
Cue Biopharma, .
Developing engineered biologics to harness the immune system for disease treatment.
About
Cue Biopharma is developing a novel class of engineered biologics that leverage the body's own immune system to treat a range of diseases. Their platform is designed to mimic natural biological signals, enabling the selective expansion and activation of specific immune cells, offering a targeted approach to immunotherapy.
Key facts
At-a-glance profile data
- Website
- cuebiopharma.com
- Headquarters
- Boston, United States
- Founded
- 2017
- Employees
- 38
- Total funding
- $10M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jan 2018 | Seed | $10M | - |
Tech stack
Detected on cuebiopharma.com, last scanned 11 Aug 2026. Run your own scan
- Frontend
- Tailwind CSS
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
Add first review
Frequently asked
How much funding has Cue Biopharma, . raised?
Cue Biopharma, . has raised a total of $10M in funding. The most recent round on record is Seed.
How many employees does Cue Biopharma, . have?
Cue Biopharma, . has approximately 38 people on record.
